GlaxoSmithKline, USPTO, Intellectual Property Office of Australia, CG Therapeutics, University of Washington, ImmuneRegen BioSciences, University of Medicine and Dentistry of New Jersey,, Stevens Proof of Concept, Stevens Institute of | GenomeWeb
Court Rules for GlaxoSmithKline in USPTO Rulemaking Case
The US District for the Eastern District of Virginia has granted summary judgment to GlaxoSmithKline and Tafas, ruling in support of GSK’s challenge to final rules issued by the US Patent and Trademark Office in August, the pharma giant said this week.
GSK said that the court essentially decided that the proposed rules are substantive in nature, and that the PTO has exceeded its rulemaking authority under the law.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.